Objective: Dobutamine (DBT), one of the most common synthetic catecholamines, is important in the renal, cardiovascular, hormonal, and central nervous systems. In our study, it is proposed to produce the first MIP-based electrochemical sensor for DBT analysis. MIP(DBT)/GCE was developed by electropolymerization of 4-aminobenzoic acid (4-ABA) in the presence of DBT. Analytical performance and validation evaluation were performed on both standard solution and commercial serum samples. Material and Method: DBT was supplied by the Vem pharmaceutical company. For the preparation of 5 mM [Fe(CN)6]3-/4- solution, known amounts of potassium ferricyanide ([K3Fe(CN)6]) and potassium ferrocyanide (K4[Fe(CN)6].3H2O mixed in 0.1 M KCl solution. The 4-ABA was used to create the polymeric film in the presence of DBT. Electrochemical measurements were actualized in IVIUM compactStat.h potentiostat (Eindhoven, The Netherlands) using a three-electrode system consisting of Pt wire, Ag/AgCl reference electrode, and glassy carbon electrode (GCE). Result and Discussion: The MIP(DBT)/GCE sensor was applied to standard solution and commercial serum samples. When DBT concentrations were plotted against ΔI values, a linear response between 1×10-13 and 1×10-12 M was obtained in both environments. LOD results were found to be 0.087×10-13 M and 0.033×10-13 M in standard solution and commercial human serum, respectively. Recovery% and RSD% were found to be 99.68-100.32% and 1.38-1.66%, respectively.